ICON names new board member
This article was originally published in Scrip
Dublin, Ireland-based ICON, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has named Dr Hugh Brady to its board of directors as a non-executive director. Dr Brady, a nephrologist by training, is president emeritus of University College Dublin, and served as president from 2004-2013.
You may also be interested in...
In the latest instalment of our VC playbook series, In Vivo sits down with Roel Bulthuis, managing partner at INKEF Capital, to discuss the group’s approach to health care investing in Europe, the importance of funding a team not just a project and how life sciences venture capital is evolving with the emergence of health tech.
Our readers have been voting and the results have been counted. The winners of In Vivo's annual Deals Of The Year contest are ...
It is time for In Vivo's 12th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.